Compare Medpace Holdings Inc (MEDP) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs NetApp Inc. — how do they compare? Medpace Holdings Inc trades at $519.93 (market cap $15.08B), while NetApp Inc. trades at $162.8 (market cap $31.57B). The key difference: NetApp Inc. is far larger — about 2.1× Medpace Holdings Inc's market cap, and NetApp Inc. pays a 1.29% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | NTAP | |
|---|---|---|
Market Cap | $15.08B | $31.57B |
Sector | Technology | Technology |
52-Week High | $620.59 | $181.08 |
52-Week Low | $308.88 | $94.11 |
Enterprise Value | $14.55B | $30.72B |
Dividend Yield | — | 1.29% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
NetApp (NTAP) trades at $161.16, down 1.66% on the day, near its pivot point of $164. The stock exhibits a bullish technical trend with strong moving average signals. Fundamentally, the company shows robust profitability with a net income margin of 18.43% and has beaten earnings estimates for three consecutive quarters. Recent strategic moves include the acquisition of DataPelago to bolster AI data infrastructure capabilities, signaling growth focus.
The outlook for NTAP is positive, driven by AI-driven demand and consistent earnings outperformance, though risks include competitive pressures and reliance on enterprise spending. Analyst consensus leans bullish with a price target of $167.45, offering modest upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
